Successful provision of CAR-T therapy during a pandemic: low SARS-CoV-2 infection rates and reduction in ICU admissions following modification of patient pathway

Leuk Lymphoma. 2022 Dec;63(13):3265-3267. doi: 10.1080/10428194.2022.2109156. Epub 2022 Aug 22.

Affiliations

¹ Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
² Department of Critical Care Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.
³ Department of Virology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.

PMID: 35994619
DOI: 10.1080/10428194.2022.2109156

No abstract available

MeSH terms

COVID-19* / epidemiology
Humans
Intensive Care Units
Pandemics
Receptors, Chimeric Antigen*
SARS-CoV-2

Substances

Receptors, Chimeric Antigen